Transaction in Own Shares

PureTech Health PLC
01 December 2023
 

01 December 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

30 November 2023



Number of ordinary shares purchased:

50,660



Highest price paid per share:

157.80p



Lowest price paid per share:

152.20p



Volume weighted average price paid per share:

154.99p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,751,624 ordinary shares in treasury and has 272,716,535 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,716,535 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

30/11/2023

08:39:55

482

157

BATE

00380380505TRLO0.1.1

30/11/2023

08:39:55

650

157

CHIX

00380380506TRLO0.1.1

30/11/2023

08:39:55

1300

157

XLON

00380380507TRLO0.1.1

30/11/2023

08:39:57

140

156.6

AQXE

00380380508TRLO0.1.1

30/11/2023

08:50:02

25

155.8

TRQX

00380382454TRLO0.1.1

30/11/2023

08:50:02

42

155.8

TRQX

00380382453TRLO0.1.1

30/11/2023

09:00:03

42

155.8

TRQX

00380383955TRLO0.1.1

30/11/2023

09:00:03

650

155.2

XLON

00380383959TRLO0.1.1

30/11/2023

09:00:03

650

155.2

XLON

00380383958TRLO0.1.1

30/11/2023

09:19:44

38

153.8

CHIX

00380386547TRLO0.1.1

30/11/2023

09:23:00

38

153.8

CHIX

00380386854TRLO0.1.1

30/11/2023

09:26:17

294

156.2

XLON

00380387214TRLO0.1.1

30/11/2023

09:26:17

282

156.2

XLON

00380387215TRLO0.1.1

30/11/2023

09:26:17

44

156.6

XLON

00380387216TRLO0.1.1

30/11/2023

09:37:04

37

154.2

CHIX

00380388930TRLO0.1.1

30/11/2023

09:40:51

37

154.2

CHIX

00380389590TRLO0.1.1

30/11/2023

09:45:21

37

154.2

CHIX

00380390494TRLO0.1.1

30/11/2023

09:49:11

37

154.2

CHIX

00380391269TRLO0.1.1

30/11/2023

09:51:32

510

155.8

XLON

00380391627TRLO0.1.1

30/11/2023

09:51:32

240

156

XLON

00380391628TRLO0.1.1

30/11/2023

10:02:36

30

154.2

CHIX

00380393438TRLO0.1.1

30/11/2023

10:05:15

18

154.2

CHIX

00380394031TRLO0.1.1

30/11/2023

10:06:19

15

154.2

CHIX

00380394133TRLO0.1.1

30/11/2023

10:07:20

14

154.2

CHIX

00380394251TRLO0.1.1

30/11/2023

10:11:38

1064

156

XLON

00380395252TRLO0.1.1

30/11/2023

10:26:40

766

156

XLON

00380398965TRLO0.1.1

30/11/2023

10:41:52

222

155.6

XLON

00380401781TRLO0.1.1

30/11/2023

10:41:52

410

155.8

XLON

00380401782TRLO0.1.1

30/11/2023

10:54:03

140

154.4

AQXE

00380403661TRLO0.1.1

30/11/2023

10:54:03

650

154.4

CHIX

00380403662TRLO0.1.1

30/11/2023

10:54:03

100

154.2

BATE

00380403663TRLO0.1.1

30/11/2023

10:54:03

382

154.2

BATE

00380403664TRLO0.1.1

30/11/2023

10:54:03

68

154.4

XLON

00380403665TRLO0.1.1

30/11/2023

10:54:03

253

154.4

XLON

00380403666TRLO0.1.1

30/11/2023

10:54:03

109

154.2

TRQX

00380403667TRLO0.1.1

30/11/2023

10:54:03

650

154.4

XLON

00380403668TRLO0.1.1

30/11/2023

11:42:28

335

155

XLON

00380410893TRLO0.1.1

30/11/2023

11:42:28

532

155.2

XLON

00380410894TRLO0.1.1

30/11/2023

12:39:12

78

156

CHIX

00380418635TRLO0.1.1

30/11/2023

12:43:02

650

155

CHIX

00380419268TRLO0.1.1

30/11/2023

12:43:14

1300

155

XLON

00380419300TRLO0.1.1

30/11/2023

12:46:46

140

154.6

AQXE

00380419942TRLO0.1.1

30/11/2023

12:46:46

109

154.6

TRQX

00380419944TRLO0.1.1

30/11/2023

12:46:46

109

154.6

TRQX

00380419943TRLO0.1.1

30/11/2023

13:23:46

1300

157.8

XLON

00380426053TRLO0.1.1

30/11/2023

13:23:46

1021

157.8

XLON

00380426054TRLO0.1.1

30/11/2023

13:45:49

236

157

BATE

00380430399TRLO0.1.1

30/11/2023

13:53:31

246

157

BATE

00380431725TRLO0.1.1

30/11/2023

13:53:31

650

157

CHIX

00380431724TRLO0.1.1

30/11/2023

13:53:31

334

157

BATE

00380431726TRLO0.1.1

30/11/2023

13:53:31

524

157

XLON

00380431727TRLO0.1.1

30/11/2023

13:53:31

766

157

XLON

00380431729TRLO0.1.1

30/11/2023

13:53:31

10

157

XLON

00380431728TRLO0.1.1

30/11/2023

13:53:31

140

156.8

AQXE

00380431731TRLO0.1.1

30/11/2023

13:53:31

140

156.8

AQXE

00380431730TRLO0.1.1

30/11/2023

13:53:31

35

156.8

TRQX

00380431733TRLO0.1.1

30/11/2023

13:53:31

72

156.8

TRQX

00380431732TRLO0.1.1

30/11/2023

13:53:31

2

156.8

TRQX

00380431734TRLO0.1.1

30/11/2023

14:06:57

164

156.6

BATE

00380434662TRLO0.1.1

30/11/2023

14:06:57

57

156.6

BATE

00380434663TRLO0.1.1

30/11/2023

14:06:57

28

156.6

CHIX

00380434664TRLO0.1.1

30/11/2023

14:15:19

261

156.6

BATE

00380436065TRLO0.1.1

30/11/2023

14:15:19

278

156.6

BATE

00380436067TRLO0.1.1

30/11/2023

14:15:19

52

156.6

BATE

00380436066TRLO0.1.1

30/11/2023

14:15:19

321

156.6

CHIX

00380436068TRLO0.1.1

30/11/2023

14:15:19

301

156.6

CHIX

00380436070TRLO0.1.1

30/11/2023

14:15:19

650

156.6

CHIX

00380436071TRLO0.1.1

30/11/2023

14:15:19

152

156.6

BATE

00380436069TRLO0.1.1

30/11/2023

14:15:19

140

156.4

AQXE

00380436072TRLO0.1.1

30/11/2023

14:15:19

1300

156.6

XLON

00380436073TRLO0.1.1

30/11/2023

14:15:19

109

156.4

TRQX

00380436074TRLO0.1.1

30/11/2023

14:30:44

630

155.4

BATE

00380439909TRLO0.1.1

30/11/2023

14:30:44

650

155.2

CHIX

00380439910TRLO0.1.1

30/11/2023

14:30:44

1950

155.4

XLON

00380439911TRLO0.1.1

30/11/2023

14:31:02

3709

154.6

XLON

00380440334TRLO0.1.1

30/11/2023

14:32:47

66

155.4

XLON

00380441615TRLO0.1.1

30/11/2023

14:32:47

268

155.4

XLON

00380441617TRLO0.1.1

30/11/2023

14:32:47

866

155.4

XLON

00380441618TRLO0.1.1

30/11/2023

14:32:47

100

155.4

XLON

00380441616TRLO0.1.1

30/11/2023

14:32:47

641

155.2

XLON

00380441619TRLO0.1.1

30/11/2023

14:41:11

140

154.8

AQXE

00380447330TRLO0.1.1

30/11/2023

14:41:11

58

154.8

AQXE

00380447331TRLO0.1.1

30/11/2023

14:41:11

109

154.8

TRQX

00380447332TRLO0.1.1

30/11/2023

15:01:21

86

154.4

XLON

00380456961TRLO0.1.1

30/11/2023

15:01:21

1300

154.8

XLON

00380456960TRLO0.1.1

30/11/2023

15:01:21

4

154.4

XLON

00380456962TRLO0.1.1

30/11/2023

15:01:39

650

154.4

CHIX

00380457094TRLO0.1.1

30/11/2023

15:01:39

482

154.4

BATE

00380457093TRLO0.1.1

30/11/2023

15:01:39

109

154

TRQX

00380457095TRLO0.1.1

30/11/2023

15:01:39

398

154.4

XLON

00380457096TRLO0.1.1

30/11/2023

15:05:40

134

153.8

XLON

00380459023TRLO0.1.1

30/11/2023

15:06:19

388

153.8

XLON

00380459422TRLO0.1.1

30/11/2023

15:06:50

396

153.8

XLON

00380459550TRLO0.1.1

30/11/2023

15:07:29

167

153.8

CHIX

00380459804TRLO0.1.1

30/11/2023

15:09:32

483

153.8

CHIX

00380460777TRLO0.1.1

30/11/2023

15:09:32

382

153.8

XLON

00380460779TRLO0.1.1

30/11/2023

15:09:32

226

153.8

XLON

00380460778TRLO0.1.1

30/11/2023

15:10:53

340

153.8

XLON

00380461261TRLO0.1.1

30/11/2023

15:14:08

1002

153.8

XLON

00380462649TRLO0.1.1

30/11/2023

15:32:42

159

153.2

AQXE

00380469770TRLO0.1.1

30/11/2023

15:32:42

63

153.2

AQXE

00380469769TRLO0.1.1

30/11/2023

15:32:42

28

153.2

AQXE

00380469771TRLO0.1.1

30/11/2023

15:32:42

432

153.2

BATE

00380469773TRLO0.1.1

30/11/2023

15:32:42

602

153.2

CHIX

00380469772TRLO0.1.1

30/11/2023

15:32:42

50

153.2

BATE

00380469775TRLO0.1.1

30/11/2023

15:32:42

319

153.2

CHIX

00380469774TRLO0.1.1

30/11/2023

15:32:42

105

153.2

XLON

00380469776TRLO0.1.1

30/11/2023

15:37:52

392

153.4

XLON

00380471188TRLO0.1.1

30/11/2023

15:54:12

188

153.6

XLON

00380476393TRLO0.1.1

30/11/2023

15:54:12

1142

153.6

XLON

00380476394TRLO0.1.1

30/11/2023

16:04:32

482

153.6

BATE

00380480291TRLO0.1.1

30/11/2023

16:04:32

613

153.6

CHIX

00380480290TRLO0.1.1

30/11/2023

16:04:35

91

153.6

XLON

00380480302TRLO0.1.1

30/11/2023

16:04:35

199

153.6

XLON

00380480303TRLO0.1.1

30/11/2023

16:05:06

37

153.6

CHIX

00380480565TRLO0.1.1

30/11/2023

16:05:06

1343

153.6

XLON

00380480566TRLO0.1.1

30/11/2023

16:05:06

112

153.4

AQXE

00380480567TRLO0.1.1

30/11/2023

16:05:06

8

153.4

XLON

00380480569TRLO0.1.1

30/11/2023

16:05:06

131

153.6

XLON

00380480568TRLO0.1.1

30/11/2023

16:05:06

642

153.4

XLON

00380480570TRLO0.1.1

30/11/2023

16:05:06

109

153.2

TRQX

00380480571TRLO0.1.1

30/11/2023

16:07:07

191

153.2

XLON

00380481326TRLO0.1.1

30/11/2023

16:13:41

1109

153.2

XLON

00380484251TRLO0.1.1

30/11/2023

16:17:08

1300

152.8

XLON

00380485991TRLO0.1.1

30/11/2023

16:19:32

490

152.6

XLON

00380487112TRLO0.1.1

30/11/2023

16:19:32

96

152.4

TRQX

00380487113TRLO0.1.1

30/11/2023

16:19:32

18

152.4

TRQX

00380487114TRLO0.1.1

30/11/2023

16:19:32

862

152.6

XLON

00380487115TRLO0.1.1

30/11/2023

16:19:32

449

152.6

XLON

00380487116TRLO0.1.1

30/11/2023

16:29:32

153

152.2

CHIX

00380491526TRLO0.1.1

30/11/2023

16:29:32

3

152.2

BATE

00380491527TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings